Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders: a comparative study

Aims: To explore differences in advanced brain magnetic resonance imaging (MRI) characteristics between myelin oligodendrocyte (MOG) immunoglobulin (IgG) and aquaporin-4 (AQP4) IgG seropositive (+) neuromyelitis optica spectrum disorders (NMOSD). Methods: 33 AQP4-IgG and 18 MOG-IgG seropositive NMOS...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schmidt, Felix (VerfasserIn) , Chien, Claudia (VerfasserIn) , Kuchling, Joseph (VerfasserIn) , Bellmann-Strobl, Judith (VerfasserIn) , Ruprecht, Klemens (VerfasserIn) , Siebert, Nadja (VerfasserIn) , Asseyer, Susanna (VerfasserIn) , Jarius, Sven (VerfasserIn) , Brandt, Alexander U. (VerfasserIn) , Scheel, Michael (VerfasserIn) , Paul, Friedemann (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 September 2020
In: Frontiers in neurology
Year: 2020, Jahrgang: 11
ISSN:1664-2295
DOI:10.3389/fneur.2020.499910
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3389/fneur.2020.499910
Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fneur.2020.499910/full
Volltext
Verfasserangaben:Felix A. Schmidt, Claudia Chien, Joseph Kuchling, Judith Bellmann-Strobl, Klemens Ruprecht, Nadja Siebert, Susanna Asseyer, Sven Jarius, Alexander U. Brandt, Michael Scheel and Friedemann Paul

MARC

LEADER 00000caa a2200000 c 4500
001 1742722350
003 DE-627
005 20220819052731.0
007 cr uuu---uuuuu
008 201214s2020 xx |||||o 00| ||eng c
024 7 |a 10.3389/fneur.2020.499910  |2 doi 
035 |a (DE-627)1742722350 
035 |a (DE-599)KXP1742722350 
035 |a (OCoLC)1341383746 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schmidt, Felix  |d 1987-  |e VerfasserIn  |0 (DE-588)1028551800  |0 (DE-627)730908941  |0 (DE-576)376028491  |4 aut 
245 1 0 |a Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders  |b a comparative study  |c Felix A. Schmidt, Claudia Chien, Joseph Kuchling, Judith Bellmann-Strobl, Klemens Ruprecht, Nadja Siebert, Susanna Asseyer, Sven Jarius, Alexander U. Brandt, Michael Scheel and Friedemann Paul 
264 1 |c 30 September 2020 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 14.12.2020 
520 |a Aims: To explore differences in advanced brain magnetic resonance imaging (MRI) characteristics between myelin oligodendrocyte (MOG) immunoglobulin (IgG) and aquaporin-4 (AQP4) IgG seropositive (+) neuromyelitis optica spectrum disorders (NMOSD). Methods: 33 AQP4-IgG and 18 MOG-IgG seropositive NMOSD patients and 61 healthy control (HC) subjects were included. All 112 participants were scanned with the same standardized MRI-protocol on a 3-Tesla MRI-scanner. Brain volume and diffusion tensor imaging (DTI) parameters were assessed. Results: MOG-IgG+ patients showed reduced parallel diffusivity within white matter tracts compared to HC whereas AQP4-IgG+ showed no significant brain parenchymal damage in DTI analysis. AQP4-IgG+ patients showed reduced whole brain volumes and reduced volumes of several deep grey matter structures compared to HC whereas MOG-IgG+ patients did not show reduced brain or deep grey matter volumes compared to HC. Conclusions: Microstructural brain parenchymal damage in MOG-IgG+ patients was more pronounced than in AQP4-IgG+ patients, compared with HC, whereas normalized brain volume reduction was more severe in AQP4-IgG+ patients. Longitudinal imaging studies are warranted to further investigate this trend in NMOSD. Our results suggest that MOG-IgG+ and AQP4-IgG+ NMOSD patients differ in cerebral MRI characteristics. Advanced MRI analysis did not help to differentiate between MOG-IgG+ and AQP4-IgG+ patients in our study. 
650 4 |a advanced imaging 
650 4 |a AQP4 
650 4 |a DTI 
650 4 |a MOG 
650 4 |a MRI 
650 4 |a NMOSD 
700 1 |a Chien, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Kuchling, Joseph  |e VerfasserIn  |4 aut 
700 1 |a Bellmann-Strobl, Judith  |e VerfasserIn  |4 aut 
700 1 |a Ruprecht, Klemens  |e VerfasserIn  |4 aut 
700 1 |a Siebert, Nadja  |e VerfasserIn  |4 aut 
700 1 |a Asseyer, Susanna  |e VerfasserIn  |4 aut 
700 1 |a Jarius, Sven  |e VerfasserIn  |0 (DE-588)1054615918  |0 (DE-627)791654818  |0 (DE-576)410367478  |4 aut 
700 1 |a Brandt, Alexander U.  |e VerfasserIn  |4 aut 
700 1 |a Scheel, Michael  |e VerfasserIn  |4 aut 
700 1 |a Paul, Friedemann  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in neurology  |d Lausanne : Frontiers Research Foundation, 2008  |g 11(2020) Artikel-Nummer 499910, 8 Seiten  |h Online-Ressource  |w (DE-627)631498753  |w (DE-600)2564214-5  |w (DE-576)326550933  |x 1664-2295  |7 nnas  |a Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders a comparative study 
773 1 8 |g volume:11  |g year:2020  |g extent:8  |a Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders a comparative study 
856 4 0 |u https://doi.org/10.3389/fneur.2020.499910  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fneur.2020.499910/full  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201214 
993 |a Article 
994 |a 2020 
998 |g 1054615918  |a Jarius, Sven  |m 1054615918:Jarius, Sven  |d 910000  |d 911100  |e 910000PJ1054615918  |e 911100PJ1054615918  |k 0/910000/  |k 1/910000/911100/  |p 8 
999 |a KXP-PPN1742722350  |e 3825358054 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Felix A. Schmidt, Claudia Chien, Joseph Kuchling, Judith Bellmann-Strobl, Klemens Ruprecht, Nadja Siebert, Susanna Asseyer, Sven Jarius, Alexander U. Brandt, Michael Scheel and Friedemann Paul"]},"id":{"doi":["10.3389/fneur.2020.499910"],"eki":["1742722350"]},"person":[{"display":"Schmidt, Felix","family":"Schmidt","given":"Felix","role":"aut"},{"display":"Chien, Claudia","given":"Claudia","role":"aut","family":"Chien"},{"role":"aut","given":"Joseph","family":"Kuchling","display":"Kuchling, Joseph"},{"display":"Bellmann-Strobl, Judith","family":"Bellmann-Strobl","role":"aut","given":"Judith"},{"display":"Ruprecht, Klemens","family":"Ruprecht","role":"aut","given":"Klemens"},{"display":"Siebert, Nadja","family":"Siebert","given":"Nadja","role":"aut"},{"role":"aut","given":"Susanna","family":"Asseyer","display":"Asseyer, Susanna"},{"display":"Jarius, Sven","role":"aut","given":"Sven","family":"Jarius"},{"family":"Brandt","given":"Alexander U.","role":"aut","display":"Brandt, Alexander U."},{"display":"Scheel, Michael","family":"Scheel","role":"aut","given":"Michael"},{"role":"aut","given":"Friedemann","family":"Paul","display":"Paul, Friedemann"}],"relHost":[{"recId":"631498753","physDesc":[{"extent":"Online-Ressource"}],"disp":"Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders a comparative studyFrontiers in neurology","origin":[{"publisher":"Frontiers Research Foundation","dateIssuedDisp":"2008-","dateIssuedKey":"2008","publisherPlace":"Lausanne"}],"title":[{"title":"Frontiers in neurology","title_sort":"Frontiers in neurology"}],"note":["Gesehen am 18.08.20","Specialty sections: Autonomic Neuroscience; Brain Imaging Methods; Dementia; Endovascular and Interventional Neurology; Epilepsy; Headache Medicine and Facial Pain; Movement Disorders; Multiple Sclerosis and Neuroimmunology; Neurocritical and Neurohospitalist; Care; Neurodegeneration; Neurogenomics; Neurology Education; Neuromuscular Diseases; Neuro-Oncology; Neuro-Ophthalmology; Neuro-Otology; Neuropediatrics; Neuropharmacology; Neuroprosthetics; Neurotrauma; Sleep and Chronobiology; Spinal Cord Medicine; Sports Neurology; Stroke; Teleneurology"],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"titleAlt":[{"title":"Autonomic Neuroscience"},{"title":"Brain Imaging Methods"},{"title":"Dementia"},{"title":"Endovascular and Interventional Neurology"},{"title":"Epilepsy"},{"title":"Headache Medicine and Facial Pain"},{"title":"Movement Disorders"},{"title":"Multiple Sclerosis and Neuroimmunology"},{"title":"Neurocritical and Neurohospitalist Care"},{"title":"Neurodegeneration"},{"title":"Neurogenomics"},{"title":"Neurology Education"},{"title":"Neuromuscular Diseases"},{"title":"Neuro-Oncology"},{"title":"Neuro-Ophthalmology"},{"title":"Neuro-Otology"},{"title":"Neuropediatrics"},{"title":"Neuropharmacology"},{"title":"Neuroprosthetics"},{"title":"Neurotrauma"},{"title":"Sleep and Chronobiology"},{"title":"Spinal Cord Medicine"},{"title":"Sports Neurology"},{"title":"Stroke"},{"title":"Teleneurology"}],"pubHistory":["2008 -"],"name":{"displayForm":["Frontiers Research Foundation"]},"part":{"year":"2020","text":"11(2020) Artikel-Nummer 499910, 8 Seiten","volume":"11","extent":"8"},"id":{"eki":["631498753"],"issn":["1664-2295"],"zdb":["2564214-5"]}}],"origin":[{"dateIssuedDisp":"30 September 2020","dateIssuedKey":"2020"}],"note":["Gesehen am 14.12.2020"],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders","title_sort":"Differences in advanced magnetic resonance imaging in MOG-IgG and AQP4-IgG seropositive neuromyelitis optica spectrum disorders","subtitle":"a comparative study"}],"physDesc":[{"extent":"8 S."}],"recId":"1742722350"} 
SRT |a SCHMIDTFELDIFFERENCE3020